FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 332:1-5 January 5, 1995 Number 1 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Serotonin-receptor antagonists seem to be as effective as corticosteroids in preventing emesis induced by moderately emetogenic antineoplastic agents. We compared the antiemetic effect of a combination of granisetron and dexamethasone with that of granisetron or dexamethasone administered alone.

Methods From December 1992 to January 1994, 428 consecutive patients who were to receive moderately emetogenic chemotherapy for the first time (600 to 1000 mg of cyclophosphamide per square meter of body-surface area, 50 mg of doxorubicin per square meter, 75 mg of epirubicin per square meter, or 300 mg of carboplatin per square meter, alone or in some combination) were enrolled in a double-blind, randomized, multicenter study evaluating the efficacy and toxicity of three antiemetic regimens. The following antiemetic regimens were used: 8 mg of dexamethasone given intravenously before chemotherapy plus 4 mg given orally immediately before chemotherapy and then every six hours for a total of four doses, 3 mg of granisetron given intravenously before chemotherapy, or a combination of granisetron and dexamethasone given in the doses used for the single-drug regimens.

Results We evaluated 408 patients (136 receiving dexamethasone, 137 receiving granisetron, and 135 receiving both drugs). In the first 24 hours after chemotherapy, complete protection from vomiting and complete protection from nausea were achieved in 70.6 and 55.1 percent, respectively, of the patients receiving dexamethasone, in 72.3 and 48.2 percent of those receiving granisetron, and in 92.6 and 71.9 percent of those receiving granisetron combined with dexamethasone (P<0.001 for all comparisons). Patients who received granisetron alone had less protection from delayed vomiting and nausea than those who received dexamethasone alone or the two drugs combined. All the regimens were equally well tolerated.

Conclusions Granisetron combined with dexamethasone was the most effective regimen for the prevention of emesis induced by moderately emetogenic chemotherapy.

Source Information

Address reprint requests to Dr. Fausto Roila at the Medical Oncology Division, Policlinico Hospital, 06122 Perugia, Italy.

Full Text of this Article

Related Letters:

Antiemetic Properties of Granisetron
Kattlove H., Pater J. L., Warr D., Roila F., Ballatori E., Del Favero A., The Italian Group for Antiemetic Research
Extract | Full Text  
N Engl J Med 1995; 332:1653-1654, Jun 15, 1995. Correspondence

This article has been cited by other articles:

• Hesketh, P. J. (2008). Chemotherapy-Induced Nausea and Vomiting. NEJM 358: 2482-2494 [Full Text]  
• Grunberg, S. (2007). Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis. Ann Oncol 18: 233-240 [Abstract] [Full Text]  
• Aapro, M., Grunberg, S., Manikhas, G., Olivares, G, Suarez, T, Tjulandin, S., Bertoli, L., Yunus, F, Morrica, B, Lordick, F, Macciocchi, A (2006). A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy. Ann Oncol 17: 1441-1449 [Abstract] [Full Text]  
• Kris, M. G., Hesketh, P. J., Somerfield, M. R., Feyer, P., Clark-Snow, R., Koeller, J. M., Morrow, G. R., Chinnery, L. W., Chesney, M. J., Gralla, R. J., Grunberg, S. M. (2006). American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006. JCO 24: 2932-2947 [Abstract] [Full Text]  
• Lu, Y.-S., Yeh, P.-Y., Chuang, S.-E., Gao, M., Kuo, M.-L., Cheng, A.-L. (2006). Glucocorticoids enhance cytotoxicity of cisplatin via suppression of NF-{kappa}B activation in the glucocorticoid receptor-rich human cervical carcinoma cell line SiHa. J Endocrinol 188: 311-319 [Abstract] [Full Text]  
• Bougouin, C., Thelcide, C., Crespin-Maillard, F., Maillard, C., Kinowski, J. M., Favier, M. (2005). Compatibility of ondansetron hydrochloride and methylprednisolone sodium succinate in multilayer polyolefin containers. Am J Health Syst Pharm 62: 2001-2005 [Abstract] [Full Text]  
• (2005). 5HT3-receptor antagonists as antiemetics in cancer. DTB 43: 57-62 [Abstract] [Full Text]  
• The Italian Group for Antiemetic Research, (2004). Randomized, Double-Blind, Dose-Finding Study of Dexamethasone in Preventing Acute Emesis Induced by Anthracyclines, Carboplatin, or Cyclophosphamide:. JCO 22: 725-729 [Abstract] [Full Text]  
• Yost, N. P., McIntire, D. D., Wians, F. H. Jr, Ramin, S. M., Balko, J. A., Leveno, K. J. (2003). A Randomized, Placebo-Controlled Trial of Corticosteroids for Hyperemesis Due to Pregnancy. Obstet Gynecol 102: 1250-1254 [Abstract] [Full Text]  
• Gralla, R., Lichinitser, M., Van der Vegt, S., Sleeboom, H., Mezger, J., Peschel, C., Tonini, G., Labianca, R., Macciocchi, A., Aapro, M. (2003). Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron. Ann Oncol 14: 1570-1577 [Abstract] [Full Text]  
• Nortcliffe, S.-A., Shah, J., Buggy, D. J. (2003). Prevention of postoperative nausea and vomiting after spinal morphine for Caesarean section: comparison of cyclizine, dexamethasone and placebo. Br J Anaesth 90: 665-670 [Abstract] [Full Text]  
• Mertens, W. C., Higby, D. J., Brown, D., Parisi, R., Fitzgerald, J., Benjamin, E. M., Lindenauer, P. K. (2003). Improving the Care of Patients With Regard to Chemotherapy-Induced Nausea and Emesis: The Effect of Feedback to Clinicians on Adherence to Antiemetic Prescribing Guidelines. JCO 21: 1373-1378 [Abstract] [Full Text]  
• Wang, J.-J., Ho, S.-T., Uen, Y.-H., Lin, M.-T., Chen, K.-T., Huang, J.-C., Tzeng, J.-I. (2002). Small-Dose Dexamethasone Reduces Nausea and Vomiting After Laparoscopic Cholecystectomy: A Comparison of Tropisetron with Saline. Anesth. Analg. 95: 229-232 [Abstract] [Full Text]  
• Kaiser, R., Sezer, O., Papies, A., Bauer, S., Schelenz, C., Tremblay, P.-B., Possinger, K., Roots, I., Brockmoller, J. (2002). Patient-Tailored Antiemetic Treatment With 5-Hydroxytryptamine Type 3 Receptor Antagonists According to Cytochrome P-450 2D6 Genotypes. JCO 20: 2805-2811 [Abstract] [Full Text]  
• Wang, J.-J., Tzeng, J.-I., Ho, S.-T., Chen, J.-Y., Chu, C.-C., So, E. C. (2002). The Prophylactic Effect of Tropisetron on Epidural Morphine-Related Nausea and Vomiting: A Comparison of Dexamethasone with Saline. Anesth. Analg. 94: 749-753 [Abstract] [Full Text]  
• Huang, J.-C., Shieh, J.-P., Tang, C.-S., Tzeng, J.-I., Chu, K.-S., Wang, J.-J. (2001). Low-dose dexamethasone effectively prevents postoperative nausea and vomiting after ambulatory laparoscopic surgery : [Une faible dose de dexamethasone previent efficacement les nausees et les vomissements postoperatoires en chirurgie laparoscopique ambulatoire]. Canadian J. Anesthesia 48: 973-977 [Abstract] [Full Text]  
• Weiss, K. S. (2001). Anaphylactic Reaction to Ondansetron. Arch Intern Med 161: 2263-2263 [Full Text]  
• Sigsgaard, T., Herrstedt, J., Handberg, J., Kjar, M., Dombernowsky, P. (2001). Ondansetron Plus Metopimazine Compared With Ondansetron Plus Metopimazine Plus Prednisolone as Antiemetic Prophylaxis in Patients Receiving Multiple Cycles of Moderately Emetogenic Chemotherapy. JCO 19: 2091-2097 [Abstract] [Full Text]  
• Subramaniam, B., Madan, R., Sadhasivam, S., Sennaraj, B., Tamilselvan, P., Rajeshwari, S., Jagan, D., Shende, D. (2001). Dexamethasone is a cost-effective alternative to ondansetron in preventing PONV after paediatric strabismus repair. Br J Anaesth 86: 84-89 [Abstract] [Full Text]  
• Tzeng, J. I., Wang, J. J., Ho, S. T., Tang, C. S., Liu, Y. C., Lee, S. C. (2000). Dexamethasone for prophylaxis of nausea and vomiting after epidural morphine for post-Caesarean section analgesia: comparison of droperidol and saline. Br J Anaesth 85: 865-868 [Abstract] [Full Text]  
• Ioannidis, J. P. A., Hesketh, P. J., Lau, J. (2000). Contribution of Dexamethasone to Control of Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Evidence. JCO 18: 3409-3422 [Abstract] [Full Text]  
• Copur, M. S., Ledakis, P., Norvell, M., Harmon, D., O'Brien, B., Roila, F., Ballatori, E., Del Favero, A. (2000). Prevention of Delayed Emesis Caused by Chemotherapy. NEJM 343: 888-890 [Full Text]  
• The Italian Group for Antiemetic Research, (2000). Dexamethasone Alone or in Combination with Ondansetron for the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy. NEJM 342: 1554-1559 [Abstract] [Full Text]  
• Kirkbride, P., Bezjak, A., Pater, J., Zee, B., Palmer, M. J., Wong, R., Cross, P., Gulavita, S., Blood, P., Sun, A., Dundas, G., Ganguly, P. K., Lim, J., Chowdhury, A. D., Kumar, S. E., Dar, A. R. (2000). Dexamethasone for the Prophylaxis of Radiation-Induced Emesis: A National Cancer Institute of Canada Clinical Trials Group Phase III Study. JCO 18: 1960-1966 [Abstract] [Full Text]  
• Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., Clark-Snow, R., Gill, D. P., Groshen, S., Grunberg, S., Koeller, J. M., Morrow, G. R., Perez, E. A., Silber, J. H., Pfister, D. G. (1999). Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines. JCO 17: 2971-2971 [Full Text]  
• Wang, J.-J., Ho, S.-T., Liu, Y.-H., Ho, C.-M., Liu, K., Chia, Y.-Y. (1999). Dexamethasone Decreases Epidural Morphine-Related Nausea and Vomiting. Anesth. Analg. 89: 117-117 [Abstract] [Full Text]  
• Wang, J.-J., Ho, S.-T., Lee, S.-C., Liu, Y.-C., Liu, Y.-H., Liao, Y.-C. (1999). The Prophylactic Effect of Dexamethasone on Postoperative Nausea and Vomiting in Women Undergoing Thyroidectomy: A Comparison of Droperidol with Saline. Anesth. Analg. 89: 200-200 [Abstract] [Full Text]  
• Armbruster, W.-J. C., Bayait, F., Papish, S. (1998). Antiemetic guidelines for low and moderately low emetogenic potential chemotherapy. J Oncol Pharm Pract 4: 212-213  
• Sherman, D. G. (1998). Heparin and heparinoids in stroke. Neurology 51: S56-S58 [Abstract] [Full Text]  
• Kettaneh, A., Biousse, V., Bousson, V., Bousser, M.-G. (1998). Roller-coaster syringomyelia. Neurology 51: 637-638 [Full Text]  
• Poewe, W. (1998). Should treatment of Parkinson's disease be started with a dopamine agonist?. Neurology 51: S21-S24 [Abstract] [Full Text]  
• Djaldetti, R., Melamed, E. (1998). Management of response fluctuations: Practical guidelines. Neurology 51: S36-S40 [Abstract] [Full Text]  
• Lennon, V. A., Kryzer, T. J. (1998). Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo"). Neurology 51: 327-328 [Full Text]  
• Tanaka, K., Motomura, M., Nakao, Y., Tanaka, M., Tsuji, S. (1998). Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo"). Neurology 51: 328-329 [Full Text]  
• Jenner, P. G., Brin, M. F. (1998). Levodopa neurotoxicity: Experimental studies versus clinical relevance. Neurology 50: S39-S43 [Abstract] [Full Text]  
• Ferguson, J. H. (1998). Breast implants redux: This time with data. Neurology 50: 849-852 [Full Text]  
• Fagan, S. C., Morgenstern, L. B., Petitta, A., Ward, R. E., Tilley, B. C., Marler, J. R., Levine, S. R., Broderick, J. P., Kwiatkowski, T. G., Frankel, M., Brott, T. G., Walker, M. D., The NINDS rt-PA Stroke Study Group*, (1998). Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology 50: 883-890 [Abstract] [Full Text]  
• Wang, Z.-Y., Okita, D. K., Howard, J. Jr., Conti-Fine, B. M. (1998). T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology 50: 1045-1054 [Abstract] [Full Text]  
• Lanska, D. J., Hartz, A. J. (1998). Measurement of quality in health care. Neurology 50: 584-587 [Full Text]  
• (1998). Management of Parkinson's disease. Neurology 50: S2-S57 [Full Text]  
• O'Suilleabhain, P., Low, P. A., Lennon, V. A. (1998). Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: Serologic and clinical correlates. Neurology 50: 88-93 [Abstract] [Full Text]  
• Tanaka, K., Motomura, M., Nakao, Y., Tanaka, M., Tsuji, S. (1997). Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo antibody-positive paraneoplastic cerebellar degeneration. Neurology 49: 895-896 [Full Text]  
• Bosl, G. J., Motzer, R. J. (1997). Testicular Germ-Cell Cancer. NEJM 337: 242-254 [Full Text]  
• Lennon, V. A. (1997). Serologic profile of myasthenia gravis and distinction from the Lambert-Eaton myasthenic syndrome. Neurology 48: 23S-27S [Abstract] [Full Text]  
• Fahn, S. (1996). Is levodopa toxic?. Neurology 47: 184S-195S [Full Text]  
• Leigh, P. N., Meldrum, B. S. (1996). Excitotoxicity in ALS. Neurology 47: 221S-227S [Abstract] [Full Text]  
• Rosenberg, N. L. (1996). Reply from the Author: Breast implants. Neurology 47: 1353-1355 [Full Text]  
• Smith, R. G., Siklos, L., Alexianu, M. E., Engelhardt, J. I., Mosier, D. R., Colom, L., Mohamed, A. H., Appel, S. H. (1996). Autoimmunity and ALS. Neurology 47: 40S-46S [Abstract] [Full Text]  
• Brannagan, T. H. III, Nagle, K. J., Lange, D. J., Rowland, L. P. (1996). Complications of intravenous immune globulin treatment in neurologic disease. Neurology 47: 674-677 [Abstract] [Full Text]  
• Bain, P. G., Motomura, M., Newsom-Davis, J., Misbah, S. A., Chapel, H. M., Lee, M. L., Vincent, A., Lang, B. (1996). Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology 47: 678-683 [Abstract] [Full Text]  
• Pace, A., Bove, L., Pietrangeli, A., Innocenti, P., Jandolo, B. (1996). Docetaxel neuropathy. Neurology 47: 615-615 [Full Text]  
• DeAngelis, L. M., Freilich, R. J. (1996). Reply from the Authors: Docetaxel neuropathy. Neurology 47: 615-615 [Full Text]  
• Folkerth, R. D., Durso, R. (1996). Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts. Neurology 46: 1219-1219 [Abstract] [Full Text]  
• Smith, A. G. (1996). Acute ventilatory failure in Lambert-Eaton myasthenic syndrome and its response to 3,4-diaminopyridine. Neurology 46: 1143-1145 [Abstract] [Full Text]  
• New, P. Z., Jackson, C. E., Rinaldi, D., Burris, H., Barohn, R. J. (1996). Peripheral neuropathy secondary to docetaxel (Taxotere). Neurology 46: 108-111 [Abstract] [Full Text]  
• Kattlove, H., Pater, J. L., Warr, D., Roila, F., Ballatori, E., Del Favero, A., The Italian Group for Antiemetic Research, (1995). Antiemetic Properties of Granisetron. NEJM 332: 1653-1654 [Full Text]  
• (1995). ANTIEMETIC REGIMENS FOR CANCER CHEMOTHERAPY COMPARED. JWatch General 1995: 4-4 [Full Text]